William Brady, DO
Pain Medicine · College Park, GANPI 1063932580
Payments from drug & device makers
What this record shows
13 manufacturers reported payments, led by Medtronic at 50.2% of the total. Reporting peaked in 2022 at $1,637 and has fallen 77.7% since, to $365 in 2025. That places this record below the midpoint for pain medicine clinicians in GA, where the typical reported total is $2,366.
Across 60 payments — averaging $45.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$1K
- Boston Scientific$672
- Nevro Corp.$217
- Abbott$155
- SPR Therapeutics, Inc$133
- Stryker$46
- plus $144 from 7 others
What the payments were for
- Travel & lodging$1,11941%
- Food & beverage$1,62459%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 22 | $1,377 |
| Boston Scientific | 12 | $672 |
| Nevro Corp. | 8 | $217 |
| Abbott | 4 | $155 |
| SPR Therapeutics, Inc | 4 | $133 |
| Stryker | 2 | $46 |
| Saol Therapeutics Inc. | 2 | $31 |
| Medline Industries LP | 1 | $27 |
| Ipsen Biopharmaceuticals, Inc | 1 | $24 |
| MML US, Inc. | 1 | $16 |
| Amarin Pharma, Inc. | 1 | $16 |
| AstraZeneca | 1 | $15 |
| Amgen | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,742 in reported general payments places this provider in the 50th percentile of 203 pain medicine providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 171 | $1,459 |
| Diclofenac Sodium | 38 | $721 |
| Duloxetine Hcl | 78 | $479 |
| Celecoxib | 11 | $397 |
| Pregabalin | 30 | $294 |
| Meloxicam | 109 | $188 |
| Tizanidine Hcl | 18 | $160 |
| Methylprednisolone | 18 | $92 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 13 | $87 |
| Tramadol Hcl | 18 | $26 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in College Park
- Rutvij ShahColumbus$86K
- Siddardth UmapathyFort Eisenhower$41K
- Susheel DuaAtlanta$36K
- Subodh AgrawalAthens$34K
- Jose MathewLawrenceville$27K
- Zhuo SunAugusta$26K
- Maged HamzaGainesville$24K
- Ankur PatelGainesville$21K
- Margaret RisoGainesville$19K
- Steven HanlingAugusta$19K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.